Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Identifying the etiology of ischemic stroke is critical to providing optimum therapy and preventing future events. Unfortunately, it is not always a simple task to establish the source, which all too often results in the diagnosis of “cryptogenic” stroke. Since cardiac sources of emboli are a well-known and significant cause of ischemic stroke, and may require different patient management, substantial effort has been made into the investigation for cardiac sources. The most important cardiac etiology for embolus is atrial fibrillation (AF), which may account for approximately 15–20% of cases of ischemic stroke. Atrial flutter, although less common, also can result in stroke, and its detection is also important.
However, not all patients with AF as the cause of stroke are known to have the diagnosis before the embolic event, nor do they necessarily present with AF at the time of the stroke. Many patients with AF have no cardiac symptoms, and the diagnosis is made only incidentally or after varying levels of search. Paroxysmal and persistent AF are considered to have a similar risk of stroke; therefore a presentation in sinus rhythm does not exclude AF as the cause of stroke. In fact, it is often in the period after the spontaneous conversion of fibrillation that embolization occurs.
After initial investigation, up to 40% of ischemic strokes are classified as cryptogenic stroke (CS) . However, subsequent evaluation has shown that a significant portion of these patients will manifest previously undiagnosed AF. The frequency of newly diagnosed AF varies but has been found in 12–30% or more of patients with CS using long-term monitoring . A number of factors influence the percentage in which AF is diagnosed in various studies, including the specific population evaluated; the extent of initial evaluation leading to the diagnosis of CS; the method, duration, and frequency of rhythm monitoring; and the duration of AF defined as relevant.
Standard practice dictates some form of initial cardiac rhythm assessment in cases of ischemic stroke of uncertain etiology. In particular, an assessment for AF is appropriate. However, due to the paroxysmal nature of many cases of AF, initial electrocardiography (ECG) alone will not detect all patients with AF. Studies looking at more extended monitoring have shown that sensitivity increases with more prolonged or repeated investigation. The optimal method and duration of monitoring remains uncertain, with several considerations influencing clinical decisions discussed later. The detection of occult AF frequently affects therapy, with anticoagulation resulting in a significantly decreased risk of recurrent stroke in these patients as compared with antiplatelet therapy alone. Extended monitoring has led to significantly increased usage of guideline-directed anticoagulation in these patients.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here